Tatsuyuki Yasuno
Corporate Officer/Principal chez EISAI CO., LTD.
Profil
Tatsuyuki Yasuno is currently the Chairman & Chief Executive Officer at Eisai, Inc., the Director at Eisai Manufacturing Ltd., and the Senior Vice President-Americas Region at Eisai Co., Ltd.
Postes actifs de Tatsuyuki Yasuno
Sociétés | Poste | Début |
---|---|---|
EISAI CO., LTD. | Corporate Officer/Principal | - |
Eisai Manufacturing Ltd.
Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The private company's official corporate website provides information on their initiatives and HHC concept. | Director/Board Member | - |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EISAI CO., LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Eisai Manufacturing Ltd.
Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The private company's official corporate website provides information on their initiatives and HHC concept. | Health Technology |